These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28363424)

  • 41. Low-level expression of microRNA-375 predicts poor prognosis in hepatocellular carcinoma.
    Zhou N; Wu J; Wang X; Sun Z; Han Q; Zhao L
    Tumour Biol; 2016 Feb; 37(2):2145-52. PubMed ID: 26349912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-21 expression predicts prognosis in hepatocellular carcinoma.
    Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
    Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):715-9. PubMed ID: 25150373
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TINCR expression is associated with unfavorable prognosis in patients with hepatocellular carcinoma.
    Tian F; Xu J; Xue F; Guan E; Xu X
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28546230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased expression of long noncoding RNA AK021443 predicts worse clinical outcome in hepatocellular carcinoma.
    Li YC; Wang D; Zhu GY
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4855-4860. PubMed ID: 30070318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
    Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
    Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS
    Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Correlation of carcinoembryonic antigen with prognosis of hepatocellular carcinoma after hepatectomy].
    Zhao J; Yan T; Bi X; Zhao H; Huang Z; Zhou J; Li Z; Li C; Cai J
    Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):430-4. PubMed ID: 25241784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection.
    Liu W; Wang N; Lu M; Du XJ; Xing BC
    Mol Med Rep; 2016 Aug; 14(2):1617-23. PubMed ID: 27315121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its Prognostic Significance in Hepatocellular Carcinoma.
    Gao J; Jia WD
    Med Sci Monit; 2019 Oct; 25():7826-7835. PubMed ID: 31626606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma.
    Cha YL; Li PD; Yuan LJ; Zhang MY; Zhang YJ; Rao HL; Zhang HZ; Zheng XF; Wang HY
    PLoS One; 2015; 10(2):e0117493. PubMed ID: 25658620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p53-induced RING-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection.
    Wang XM; Yang LY; Guo L; Fan C; Wu F
    Cancer; 2009 Oct; 115(19):4554-63. PubMed ID: 19551892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical markers for hepatocellular carcinoma prognosis after liver resection and liver transplantation.
    Lee SH; Lee JS; Na GH; You YK; Kim DG
    Clin Transplant; 2017 Jan; 31(1):. PubMed ID: 27653235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance of receptor for advanced glycation end products expression in hepatocellular carcinoma after hepatectomy.
    Ito R; Ishii Y; Wakiyama S; Shiba H; Fujioka S; Misawa T; Ishida Y; Hano H; Yanaga K
    J Surg Res; 2014 Dec; 192(2):503-8. PubMed ID: 25043528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulated expression of DIXDC1 in hepatocellular carcinoma and its correlation with prognosis.
    Zhou S; Shen J; Lin S; Liu X; Xu M; Shi L; Wang X; Cai X
    Tumour Biol; 2016 Oct; 37(10):13607-13616. PubMed ID: 27468723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
    Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C
    Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.